Why the long-term outlook for biotech sector remains intact

The healthcare sector has been under a black cloud since the US Presidential Election last year, driven by concerns over drug pricing.

President Donald Trump's sharp criticism of the high cost of medicines in the US indicated he would take a tough stance against the industry.  However, in recent weeks there have been reports that Trump is preparing an executive order which will not push down pricing. In fact, this order could do the very opposite: it would allow healthcare companies to give even fewer discounts to hospitals and low income people as well as giving the sector more power to charge monopoly prices in other countries. Healthcare innovation set to drive sustainable returns The administration might al...